United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen healthcare ltd - alitretinoin - oral capsule - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen healthcare ltd - alitretinoin - oral capsule - 30mg

United States - English - NLM (National Library of Medicine)

eisai inc. - alitretinoin (unii: 1ua8e65kdz) (alitretinoin - unii:1ua8e65kdz) - alitretinoin 60 mg in 60 g - panretin® gel is indicated for topical treatment of cutaneous lesions in patients with aids-related kaposi’s sarcoma. panretin® gel is not indicated when systemic anti-ks therapy is required (e.g., more than 10 new ks lesions in the prior month, symptomatic lymphedema, symptomatic pulmonary ks, or symptomatic visceral involvement). there is no experience to date using panretin® gel with systemic anti-ks treatment. panretin® gel is contraindicated in patients with a known hypersensitivity to retinoids or to any of the ingredients of the product.

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - alitretinoin - capsules soft - alitretinoin 10 mg - alitretinoin - alitretinoin - for use in adults who have severe chronic hand eczema that is unresponsive to treatment with potent topical corticosteroids .patients in whom the eczema has predominantly hyperkeratotic features are more likely to respond to treatment than in those in whom the eczema predominantly presents as pompholyx .

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - alitretinoin - capsules soft - alitretinoin 30 mg - alitretinoin - alitretinoin - for use in adults who have severe chronic hand eczema that is unresponsive to treatment with potent topical corticosteroids .patients in whom the eczema has predominantly hyperkeratotic features are more likely to respond to treatment than in those in whom the eczema predominantly presents as pompholyx .

United States - English - NLM (National Library of Medicine)

ligand pharmaceuticals incorporated - alitretinoin (unii: 1ua8e65kdz) (alitretinoin - unii:1ua8e65kdz) - gel - 1 mg in 1 g - panretin® gel is indicated for topical treatment of cutaneous lesions in patients with aids-related kaposi’s sarcoma. panretin® gel is not indicated when systemic anti-ks therapy is required (e.g., more than 10 new ks lesions in the prior month, symptomatic lymphedema, symptomatic pulmonary ks, or symptomatic visceral involvement). there is no experience to date using panretin® gel with systemic anti-ks treatment. panretin® gel is contraindicated in patients with a known hypersensitivity to retinoids or to any of the ingredients of the product.

Malta - English - Medicines Authority

glaxo smithkline uk limited 980 great west road, brentford, middlesex, tw8 9gs, united kingdom - alitretinoin - soft capsule - alitretinoin 10 mg - other dermatological preparations

Malta - English - Medicines Authority

glaxo smithkline uk limited 980 great west road, brentford, middlesex, tw8 9gs, united kingdom - alitretinoin - soft capsule - alitretinoin 30 mg - other dermatological preparations

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - alitretinoin - oral capsule - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - alitretinoin - oral capsule - 30mg